<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>13</Volume>
				<Issue>11</Issue>
				<PubDate PubStatus="epublish">
					<Year>2012</Year>
					<Month>11</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Curcumin Inhibits TGF-β1-Induced MMP-9 and Invasion through ERK and Smad Signaling in Breast Cancer MDAMB- 231 Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>5709</FirstPage>
			<LastPage>5714</LastPage>
			<ELocationID EIdType="pii">27104</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: To evaluate the effects of curcumin on matrixmetalloproteinase-9 (MMP-9) and invasion abilityinduced by transforming growth factor-β1 (TGF-β1) in MDA-MB-231 cells and potential mechanisms. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;:Human breast cancer MDA- MB-231 cells were used with the CCK-8 assay to measure the cytotoxicity ofcurcumin. After treatment with 10 ng/ml TGF-β1, with or without curcumin (≤10 μM), cell invasion was checkedby transwell chamber. The effects of curcumin on TGF-β1-stimulated MMP-9 and phosphorylation of Smad2,extracellular-regulated kinase (ERK), and p38 mitogen activated protein kinases (p38MAPK) were examined byWestern blotting. Supernatant liquid were collected to analyze the activity of MMP-9 via zymography. Followingtreatment with PD98059, a specific inhibitor of ERK, and SB203580, a specific inhibitor of p38MAPK, Westernblotting and zymography were employed to examine MMP-9 expression and activity, respectively. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Lowdose curcumin (≤10 μM) did not show any obvious toxicity to the cells, while 0~10 μmol/L caused a concentration–dependent reduction in cell invasion provoked by TGF-β1. Curcumin also markedly inhibited TGF-β1-regulatedMMP-9 and activation of Smad2, ERK1/2 and p38 in a dose- and time-dependent manner. Additionally, PD98059,but not SB203580, showed a similar pattern of inhibition of MMP-9 expression. &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;: Curcumin inhibitedTGF-β1-stimulated MMP-9 and the invasive phenotype in MDA-MB-231 cells, possibly associated with TGF-β/Smad and TGF-β /ERK signaling.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">curcumin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">TGF-β1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MMP-9</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MAPKs</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Invasion</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_27104_60bd97b690604f89d343018532701cc5.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
